GoodRx Holdings (GDRX) Cash from Investing Activities (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Cash from Investing Activities data on file, last reported at -$21.6 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities rose 58.28% year-over-year to -$21.6 million; the trailing twelve-month figure through Mar 2026 stood at -$89.7 million (up 11.69% YoY), and the FY2025 full-year result was -$120.0 million, down 70.53% from the prior year.
• Cash from Investing Activities improved to -$21.6 million in Q1 2026, from -$31.8 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $1.3 million in Q4 2022 to a low of -$163.6 million in Q2 2022.
• A 5-year average of -$28.1 million and a median of -$17.2 million in 2024 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities surged 113.89% in 2022 and tumbled 1100.93% in 2023, its largest moves.
• Tracing GDRX's Cash from Investing Activities over 5 years: stood at $1.3 million in 2022, then plunged by 1100.93% to -$12.9 million in 2023, then fell by 29.3% to -$16.6 million in 2024, then plunged by 90.88% to -$31.8 million in 2025, then jumped by 31.87% to -$21.6 million in 2026.
• Business Quant data shows GDRX's Cash from Investing Activities at -$21.6 million in Q1 2026, -$31.8 million in Q4 2025, and -$18.0 million in Q3 2025.